FDA Discusses Effective Patient Engagement at #BIOSummit19

For the FDA, engagement with patients, caregivers and patient advocacy organizations is a vital part of the drug development and review process. However, how that engagement happens can determine how successful it is.
This was the key question addressed by the “Practices and Principles: Navigating the FDA” panel on day one of BIO’s Patient and Health Advocacy Summit. 
 
“It’s really been heartening to see the ways that not just the FDA but industry is inco